Delhi, November 2019, 26-28: VelaLabs will be sharing a booth together with Megsan Labs at the CPhI India. In June 2019, the Tentamus Group has acquired a majority stake of the leading Indian analytical testing services company for pharmaceuticals, Megsan Labs (Hyderabad). Megsan Labs brings complementary, value-added and differentiated analytical, testing and development capabilities for all stages of drug development and commercialization to the Tentamus Group. VelaLabs offers array of all kinds of (bio)analytical services, bioassays and structural-related methods especially for biopharmaceuticals, biosimilars & biologics. The combined participation of VelaLabs together with FDAS (a Tentamus subsidiary in UK) and Megsan Labs is now one of the first steps for a fruitful collaboration and growing together within the Tentamus group.